This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

Credit: Getty Images Osteoporosis presents a significant medical burden, yet screening rates among men remain low. Osteoporosis is widely regarded as a silent disease — right up until the moment a ...

Parkland Corp.‘s long-serving chief executive Bob Espey says he will step down in a bid to resolve the embattled fuel retailer’s troubles with activist shareholders. The announcement comes as the ...

Roche is investigating Columvi as a monotherapy and in combination with other medicines for the treatment of diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma. As part of Roche’s efforts ...

diffuse large B-cell lymphoma (DLBCL) not otherwise specified who are ineligible for autologous stem cell transplant (ASCT). With this approval, this Columvi combination is the first bispecific ...

Roche has secured approval from the European Commission (EC) for Columvi (glofitamab) plus gemcitabine and oxaliplatin (GemOx) combo to treat adults with relapsed or refractory (R/R) diffuse large ...

Helen Rushbrook/Stocksy Past studies show that people can help lower their osteoporosis risk through certain lifestyle habits, such as eating a well-balanced diet and maintaining a healthy weight.